Structural and Functional Dysbiosis of Fecal Microbiota in Chinese Patients With Alzheimer's DiseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers compared fecal microbiota structure and function between 100 Chinese patients with Alzheimer's disease and 71 age and gender matched cognitively normal controls.
How was it studied?
The team sequenced the V3-V4 region of the 16S rRNA gene by MiSeq in stool samples from both groups, then correlated taxonomic shifts with MMSE, WAIS, and Barthel clinical scores.
What did they find?
Alzheimer's patients showed markedly reduced bacterial diversity. Butyrate producing genera such as Faecalibacterium decreased and correlated positively with cognitive and functional scores, while lactate producing genera such as Bifidobacterium increased and correlated inversely with those scores. Predicted functional modules for fatty acid biosynthesis and metabolism were also altered.
Why it matters
A shift from butyrate producers to lactate producers may drive immune disturbances in Alzheimer's patients. The authors suggest gut bacteria could serve as non-invasive biomarkers for early diagnosis and inform tailor-made probiotics.